Oxford Biodynamics Plc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Oxford Biodynamics Plc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011410
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neurodegenerative conditions. Its biomarker discovery platform is used for the detection of aberrant gene expression. The company’s products are used in the areas of breast cancer diagnostics, hepatocellular carcinoma diagnostics, nasopharyngeal carcinoma diagnostics, prostate cancer progression, melanoma diagnostics, and age related disease diagnostics. Oxford Bio is headquartered in Oxford, the UK.

Oxford Biodynamics Plc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Oxford Biodynamics Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Oxford Biodynamics Plc, Medical Equipment, Deal Details 11
Venture Financing 11
Oxford Biodynamics Raises US$3.2 Million In Financing 11
Partnerships 12
Nova Satra Enters into Licensing Agreement with Oxford BioDynamics 12
Oxford Biodynamics Enters Into Agreement With University of Glasgow For Epigenetic Biomarkers 13
Equity Offering 14
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 14
Oxford Biodynamics Plc – Key Competitors 15
Oxford Biodynamics Plc – Key Employees 16
Oxford Biodynamics Plc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Jun 13, 2017: Oxford Biodynamics Interim Results For The Six-Month Period Ended 31 March 2017 18
Jan 31, 2017: Oxford BioDynamics Announces Final Results for the Year Ended 30 September 2016 24
Corporate Communications 26
Sep 15, 2017: Oxford BioDynamics appoints Paul Stockdale as Chief Financial Officer and Executive Director on the Board 26
Jun 30, 2017: Oxford BioDynamics: Appointment of Paul Stockdale as Chief Financial Officer 27
Mar 09, 2017: Oxford BioDynamics announces appointment of Martin Reeves as Senior Vice President of Commercial Development 28
Feb 13, 2017: Oxford BioDynamics appoints Dr Claudio Carini as an Advisor 29
Product News 30
Nov 15, 2017: Oxford BioDynamics presents latest immunotherapy data at the NIH Biomarker Consortium Cancer Steering Committee Annual Symposium, in Washington, DC 30
Oct 13, 2017: Oxford BioDynamics presents at the Diabetes Asia 2017 Conference 31
Oct 11, 2017: Oxford BioDynamics presents ALS signatures at NEALS 32
Oct 03, 2017: Oxford BioDynamics announces grant of US patent for its proprietary technology platform, EpiSwitch 33
May 31, 2017: Nature (Scientific Reports) publication highlights advantages of EpiSwitch technology platform 34
Dec 12, 2016: Oxford BioDynamics presents applications of its epigenetic biomarker technology EpiSwitch at the annual meeting of the American Society of Hematology in San Diego 35
Nov 02, 2016: Oxford BioDynamics presents applications of its epigenetic biomarkers technology at the 2nd International Annual Companion Diagnostic Summit in Berlin 36
Oct 25, 2016: Oxford BioDynamics presents results of study into epigenetic biomarkers for ALS at The Lancet Neurology Conference 37
Jan 12, 2016: Biotechnology firm Oxford BioDynamics expands its biomarker discovery programme for ALS diagnosis 38
Other Significant Developments 39
May 23, 2017: Oxford BioDynamics enters into development agreement with two top 10 global pharmaceutical companies 39
Jan 23, 2017: Oxford BioDynamics enters into pilot project with EpiFit to analyse the effect of fitness regimes using EpiSwitch 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42

List of Tables
Oxford Biodynamics Plc, Medical Equipment, Key Facts 2
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Oxford Biodynamics Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Oxford Biodynamics Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Oxford Biodynamics Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Oxford Biodynamics Plc, Deals By Market, 2011 to YTD 2017 9
Oxford Biodynamics Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Oxford Biodynamics Raises US$3.2 Million In Financing 11
Nova Satra Enters into Licensing Agreement with Oxford BioDynamics 12
Oxford Biodynamics Enters Into Agreement With University of Glasgow For Epigenetic Biomarkers 13
Oxford BioDynamics Raises USD24.9 Million in Issue of New Ordinary Shares 14
Oxford Biodynamics Plc, Key Competitors 15
Oxford Biodynamics Plc, Key Employees 16
Oxford Biodynamics Plc, Other Locations 17

★海外企業調査レポート[Oxford Biodynamics Plc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Methode Electronics Inc (MEI):企業の財務・戦略的SWOT分析
    Summary Methode Electronics Inc (Methode) is technology company. The company offers products such as automotive and transportation, high voltage switchgear, high-speed copper transceivers and modules, bus bars, custom user interface, dabir surfaces, discrete and analog switching, emi receptacles, fo …
  • Avient Corp (POL):企業の財務・戦略的SWOT分析
    Avient Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Sonoco Products Co (SON):企業の財務・戦略的SWOT分析
    Sonoco Products Co (SON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • PaxVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PaxVax Inc (PaxVax) is a vaccine company that develops and commercializes specialty vaccines against infectious diseases. The company develops scalable, and oral vaccines. Its activities include early-stage preclinical research and development, clinical study support, drug product manufactur …
  • Mizuno Corp (8022):企業の財務・戦略的SWOT分析
    Mizuno Corp (8022) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Host Hotels & Resorts Inc (HST):企業の財務・戦略的SWOT分析
    Host Hotels & Resorts Inc (HST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Veracyte Inc (VCYT):企業の製品パイプライン分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products comprise Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It als …
  • Team Health Holdings Inc-製薬・医療分野:企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • JSC Halyk Bank:企業の戦略・SWOT・財務情報
    JSC Halyk Bank - Strategy, SWOT and Corporate Finance Report Summary JSC Halyk Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Korea Midland Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Midland Power Co., Ltd. (Komipo), a subsidiary of Korea Electric Power Corporation, is an electric utility which generates electricity; operates power plants; and provides various energy services. The company produces electricity from bituminous coal, anthracite coal, liquefied natural …
  • Andhra Pradesh Power Generation Corp Ltd:企業の戦略的SWOT分析
    Andhra Pradesh Power Generation Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Choppies Enterprises Limited (CHOPPIES):企業の財務・戦略的SWOT分析
    Choppies Enterprises Limited (CHOPPIES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Cyteir Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Cyteir Therapeutics Inc (Cyteir Therapeutics) discovers, develops and commercializes synthetic lethal therapeutics for the treatment of cancer and autoimmune disease. It specializes in the development of small molecules that targets RAD51 to induce synthetic lethality in diseases with a gain …
  • Meiji Co Ltd:企業の戦略・SWOT・財務情報
    Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Meiji Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Holland America Line Inc:企業の戦略的SWOT分析
    Holland America Line Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Eddingpharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eddingpharm Inc (Eddingpharm) is a pharmaceutical company that manufactures and distributes medicines. The company develops products in therapeutic areas such as clinical nutrition, antibiotics, respiratory system, nephrology and cardiovascular. It offers antibiotics including vancocin, cecl …
  • Raiffeisen Bank International AG:企業の戦略・SWOT・財務情報
    Raiffeisen Bank International AG - Strategy, SWOT and Corporate Finance Report Summary Raiffeisen Bank International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • LG Electronics, Inc.:企業の戦略・SWOT・財務情報
    LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report Summary LG Electronics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆